CardioFocus Launches Trial for HeartLight Device

 CardioFocus is launching a clinical trial for its HeartLight direct-visualization ablation device for treating atrial fibrillation.

The device enables electrophysiologists to control the delivery of laser energy through direct visual guidance to isolate pulmonary veins with a high procedural flexibility.

The first HeartLight version won pre-market approval from the FDA in April 2016.